Author:
Corona Giuseppe,Elia Caterina,Casetta Bruno,Diana Crivellari,Rosalen Sara,Bari Mario,Toffoli Giuseppe
Reference17 articles.
1. Experience with exemestane in the treatment of early and advanced breast cancer;Lonning;Expert Opinion on Drug Metabolism and Toxicology,2008
2. Exemestane (FCE 24304), a new steroidal aromatase inhibitor;di Salle;Journal of Steroid Biochemistry and Molecular Biology,1992
3. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients;Geisler;Clinical Cancer Research,1998
4. Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial;Coombes;Lancet,2007
5. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer;Lonning;Journal of Clinical Oncology,2005
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献